4YD0

Influenza polymerase basic protein 2 (PB2) bound to an azaindole-tetrazole inhibitor

Summary for 4YD0

Entry DOI	10.2210/pdb4yd0/pdb
Descriptor	Polymerase basic protein 2, 2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoro-N-[(1R,2S,3S,4R)-3-(1H-tetrazol-5-yl)bicyclo[2.2.2]oct-2-yl]pyrimidin-4-amine (3 entities in total)
Functional Keywords	small-molecule drug, inhibitor, flu, m7-gtp pocket, transcription-inhibitor complex, transcription/inhibitor
Biological source	Influenza A virus
Cellular location	Virion: Q30NP1
Total number of polymer chains	1
Total formula weight	19614.20
Authors	Jacobs, M.D. (deposition date: 2015-02-20, release date: 2015-04-15, Last modification date: 2024-02-28)
Primary citation	Boyd, M.J.,Bandarage, U.K.,Bennett, H.,Byrn, R.R.,Davies, I.,Gu, W.,Jacobs, M.,Ledeboer, M.W.,Ledford, B.,Leeman, J.R.,Perola, E.,Wang, T.,Bennani, Y.,Clark, M.P.,Charifson, P.S. Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors. Bioorg.Med.Chem.Lett., 25:1990-1994, 2015 Cited by PubMed: 25827523 DOI: 10.1016/j.bmcl.2015.03.013 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.62 Å)

Structure validation